Signalling from dead cells drives inflammation and vessel remodelling

Area of Science:

• Cardiovascular Biology
• Cellular Pathology
• Immunology

Background:

• Vascular smooth muscle cell (VSMC) death is implicated in vessel development, disease (e.g., atherosclerosis), injury, and aging.
• VSMC loss contributes to plaque vulnerability, elastin fragmentation, and calcification.
• Apoptosis of VSMCs can lead to inflammation via secondary necrosis if phagocytosis is inefficient.

Purpose of the Study:

• To investigate the consequences of VSMC apoptosis in both disease and normal vessel remodeling.
• To determine the specific cytokine profiles released by VSMCs depending on the mode of cell death (apoptosis vs. necrosis).
• To elucidate how these cytokine signals influence subsequent cellular responses and vascular outcomes.

Main Methods:

• Analysis of cytokine release from VSMCs undergoing apoptosis and necrosis.
• Investigation of the effects of released cytokines (IL-1α, IL-1β, IL-6, MCP-1) on adjacent vascular cells.
• Correlation of cytokine signaling patterns with specific pathological or repair-oriented vascular changes.

Main Results:

• VSMCs release distinct cytokines based on cell death mode: IL-1β during apoptosis and IL-1α during necrosis.
• Both IL-1α and IL-1β stimulate adjacent cells to release further cytokines, notably IL-6 and MCP-1.
• The resulting cytokine milieu dictates whether VSMC death promotes inflammation, neointima formation, or vascular repair through VSMC proliferation and migration.

Conclusions:

• VSMC death is a critical determinant of vascular health, capable of initiating either pathological processes or repair mechanisms.
• Cytokine signaling, particularly the balance of IL-1α, IL-1β, IL-6, and MCP-1, is central to mediating these divergent outcomes.
• Understanding the context-dependent nature of VSMC death and its associated cytokine release is crucial for developing targeted therapies for cardiovascular diseases.